Obesity overweight/fatness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18*30 years 2. Male gender 3. Caucasian 4. BMI 20*25 kg/m2 5. Normal insulin sensitivity 6. Normoglycemia at time of screening 7. Normal diet pattern 8. Stable body weight during 6 months before enrolment in the study (
Exclusion criteria
Exclusion criteria: 1. Presence of any relevant disease 2. Use of any relevant medication 3. First-degree relative with type 2 diabetes 4. Smoking 5. Shift work 6. A history of chronic glucocorticoids use or GC use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Metabolic insulin sensitivity: rate of disappaerance (Rd) en endogenous glucose production (EGP) 2. Vascular insuline senitivityt: changes in microvascular blood volume (MBV) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Microvascular vasoreactivity in vitro with and without PVAT (myograph technique) 2. Insulin mediated protein expression and activation in microvessels, adipose and skeletal muscle tissue 3. Gen expression of insulin signaling genes in endothelial cells 4. PVAT morphology/characteristics, including adipocyte size, celltypes and expression of adipokines 5. Plasma insulin, glucose, lipid spectrum, inflammatory parameters 6. Physical activity (by means of accelerometry) 7. Gut microbiota composition (fecal analysis) | — |
Countries
Netherlands